You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A cost-effective bioreactor to advance functional tissue engineering of cartilage

    SBC: Apex Biomedical Company, LLC            Topic: NIAMS

    DESCRIPTION (provided by applicant): Osteoarthritis (OA) is the leading cause of chronic disability in the United States. A clinical goal in the treatment and prevention of OA is to develop replacement cartilage using tissue engineering (TE) technologies. Although TE cartilage presently lacks the mechanical stability of native cartilage, studies have demonstrated that mechanical stability can be e ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  2. Acute-infarct selective cardiac MRI contrast agent

    SBC: ELGAVISH PARAMAGNETICS, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant The overall goal of this project is to demonstrate the ability of our acute myocardial infarct selective paramagnetic contrast agent Gadolinium ABE DTTA to differentiate between acute and chronic infarcts in a reliable manner using contrast enhanced magnetic resonance imaging ceMRI In our Phase I data we have shown that Gd ABE DTTA exclusively highlight ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  3. A Device to Quantify Sweat of Single Sweat Glands to Diagnose Neuropathy

    SBC: Neuro Devices, Inc.            Topic: 107

    DESCRIPTION provided by applicant We devised a new generation highly sensitivity method to diagnosis peripheral neuropathy early when the probability for reversal is greatest Cancer chemotherapy and diabetes are the most common causes of neuropathy in the USA Both cause decreased sweating abnormal circulation peripheral numbness pain and weakness If diagnosed early both are potentially ...

    STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  4. A dual histone deacetylase and glycogen synthase kinase 3 beta inhibitor for treating pancreatic adenocarcinoma

    SBC: Avenzoar Pharmaceuticals, Inc.            Topic: 102

    ABSTRACT Pancreatic cancer is a disease with no effective treatmentIt s low five year survival rateestimated at betweenandranks it the fourth highest of cancer related of death in the U Sdespite being the twelfth most common type of cancerEach year in the U Sthere are nearlynew cases and more thandeaths caused by the diseaseBypancreatic cancer is expected to be the second most common cancer relate ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  5. Advanced Gas Sensing Technology for Space Suits

    SBC: INTELLIGENT OPTICAL SYSTEMS, INC.            Topic: T6

    The gas sensor in the PLSS of the ISS EMU will meet its projected life in 2020, and NASA is planning to replace it. At present, only high TRL devices based on infrared absorption are candidate replacements, because of their proven long-term stability, despite their size and power consumption and failures in the presence of liquid water. No current compact sensor has the tolerance for liquid water ...

    STTR Phase II 2019 National Aeronautics and Space Administration
  6. Advanced Li/CFx Primary Batteries with Non-Flammable Electrolytes

    SBC: CFX BATTERY, INC.            Topic: T601

    NASA seeks to develop high specific energy primary batteries that are safe and capable of performing under a wide temperature range, for manned space missions. To meet this goal, CFX Battery Inc. proposes to develop, characterize, and establish technological feasibility of a new Li/SF-CFx based high capacity lithium primary battery that offers higher rate capability and enhanced safety than conven ...

    STTR Phase I 2010 National Aeronautics and Space Administration
  7. Advanced Simulation Framework for Design and Analysis of Space Propulsion Systems

    SBC: STREAMLINE NUMERICS, INC.            Topic: T901

    The innovation proposed here is a high-performance, high-fidelity framework in the computational fluid dynamics (CFD) code called Loci-STREAM to enable accurate, fast and robust simulations of unsteady multiphase flows such as combustion involving liquid-gas phases in liquid rocket injectors and solid-gas phases in solid rocket motors, and cryogenic cavitation in delivery systems of liquid rocket ...

    STTR Phase II 2010 National Aeronautics and Space Administration
  8. Advanced Structural Health Monitoring System for Comprehensive Real-Time Vehicle Characterization

    SBC: AMERICAN GNC CORPORATION            Topic: T1

    In providing an innovative solution to improving information technologies and health management systems, AGNC is proposing a significant technological achievement with the Advanced Structural Health Monitoring System for Comprehensive Real-Time Vehicle Characterization. During in-flight conditions, this system is able to not only provide the status of information such as regarding the flight envel ...

    STTR Phase I 2010 National Aeronautics and Space Administration
  9. Advanced Unsteady Turbulent Combustion Simulation Capability for Space Propulsion Systems

    SBC: STREAMLINE NUMERICS, INC.            Topic: T901

    The innovation proposed here is a high performance, high fidelity simulation capability to enable accurate, fast and robust simulation of unsteady turbulent, reacting flows involving cryogenic propellants (such as LOX/LH2 and LOX/LCH4). The key features of this proposed capability are: (a) Hybrid RANS-LES (HRLES) methodology, and (b) flamelet modeling for turbulent combustion incorporated in a pr ...

    STTR Phase I 2010 National Aeronautics and Space Administration
  10. Advancing clemizole for hepatitis C: towards a pre-IND package

    SBC: EIGER GROUP INTERNATIONAL, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Over 150 million people worldwide are infected with the hepatitis C virus (HCV), which is an important cause of chronic liver disease. Current therapies are inadequate. Our long-term objective is to bring a new class of anti-HCV drugs to the clinic. We recently discovered and genetically validated a new target within the HCV non-structural protein NS4B, consist ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government